Research

Amyotrophic Lateral Sclerosis is a progressive neurodegenerative disease that attacks nerve cells in the brain and the spinal cord. The foundation supports ALS research while aiming to improve the quality of life of patients.

The $100,000 prize is an internationally recognized tribute for advancing dementia research. As part of an international ... only for frontotemporal dementia (FTD), but also for amyotrophic lateral sclerosis (ALS), also known as Lou Gehrig's disease.

Benyo will push DiMarzo, who has amyotrophic lateral sclerosis, in a custom wheelchair designed for ... the Boston Marathon to raise awareness of and funds for breakthrough ALS research underway at UMass Medical School. ALS is a progressive ...

Zacks Investment Research lowered shares of Voyager Therapeutics Inc ... s disease and preclinical programs comprise VY-SOD101 for a monogenic form of amyotrophic lateral sclerosis, VY-FXN01 for Friedreich ataxia and VY-HTT01 for Huntington’s disease ...

Maple syrup helps protect neurons and keep the brain healthy, a new research has found ... chances of developing symptoms of paralysis that are comparable to amyotrophic lateral sclerosis (ALS). This brain health benefit was brought by the presence ...

Jim Worthington, the Bucks County businessman who owns the Newtown Athletic Club, has been recognized for his support of research for a cure into ... The program seeks to develop a treatment for amyotrophic lateral sclerosis, a progressive ...

Amyotrophic lateral sclerosis is a rare neuromuscular disease that causes ... Parker is funded by the Fondation du CHUM, ALS Canada, the Canadian Health Research Institutes, le Fonds de recherche du Québec – Santé, and the American Muscular Dystrophy ...

A number of other research firms have also weighed in on VYGR ... including advanced Parkinson’s disease; a monogenic form of amyotrophic lateral sclerosis; Friedreich’s ataxia; Huntington’s disease, and spinal muscular atrophy.

Zacks Investment Research downgraded shares of Voyager Therapeutics ... s disease and preclinical programs comprise VY-SOD101 for a monogenic form of amyotrophic lateral sclerosis, VY-FXN01 for Friedreich ataxia and VY-HTT01 for Huntington’s disease ...

ALS, or amyotrophic lateral sclerosis, also known as Lou Gehrig’s disease ... and assist families that have been affected by raising money for scholarships and research.” Last year, the schools raised over $500 for the P.H.A.A.L.S. Foundation to ...